ArticleBlood research2025

Relative efficacy of systemic treatments for patients with relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis according to 17p deletion/TP53 mutations.

Jinchul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.